DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HD11K29

Real-time BOERSE MUENCHEN 07:15:54 04/06/2024 pm IST
1.3 EUR +4.00% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+1.63%
1 month-8.09%
Date Price Change
04/24/04 1.3 +4.00%
03/24/03 1.25 +1.63%
31/24/31 1.23 +0.82%
30/24/30 1.22 +6.09%
29/24/29 1.15 -10.85%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 07:15 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD11K2
ISINDE000HD11K29
Date issued 30/11/2023
Strike 42
Maturity 18/09/2024 (106 Days)
Parity 1 : 1
Emission price 1.61
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.97
Lowest since issue 0.59
Spread 0.03
Spread %2.31%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.25 EUR
Average target price
39.97 EUR
Spread / Average Target
+1.84%
Consensus